Fundamentally, Biolife Solutions Inc. (BLFS) is stronger than ever: year-to-year revenue growth of +29%, Gross Margins of 72%, successful recent acquisition of two tissue storage/transport companies that will add to the top and bottom lines, an ever-increasing list of customers, and positive net income - a feat difficult to achieve for most rapidly growing biotechs.
And yet, the strengthening fundamental position has resulted in seven months of choppy sideways price action, trying the patience of all Biolife Solutions investors, myself included. So what gives?
Investment Thesis: The sideways price action is not indicative